BDR Pharma Launches Favipiravir at Rs 63 per Tablet for Treatment of COVID-19
BDR Pharmaceuticals, a Mumbai based drug company, on Wednesday announced the launch of its antiviral drug Favipiravir for the treatment of coronavirus patients in India....